Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study

被引：0
|
作者：
Weihong Zeng [1 ]
Tiansheng Wang [2 ]
Til Stürmer [2 ]
Na He [3 ]
Peng Shen [4 ]
Hongbo Lin [4 ]
Xiaodong Guan [1 ]
Yang Xu [1 ]
机构：
[1] Peking University,Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center
[2] University of North Carolina at Chapel Hill,Department of Epidemiology, Gillings School of Global Public Health
[3] Peking University Third Hospital,Department of Pharmacy
[4] Yinzhou District Center for Disease Control and Prevention,Department of Chronic Disease and Health Promotion
来源：
Cardiovascular Diabetology | / 24卷 / 1期
关键词：
Type 2 diabetes mellitus; Older; Angiotensin-converting enzyme inhibitors; Angiotensin II receptor blockers; Major cardiovascular events.;
D O I：
10.1186/s12933-025-02753-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus
    Hughes, DB
    Britton, ML
    PHARMACOTHERAPY, 2005, 25 (11): : 1602 - 1620
  • [2] Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany
    Adarkwah, Charles Christian
    Gandjour, Afschin
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (01) : 62 - 70
  • [3] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension
    Kuan, Yi-Chun
    Huang, Kuang-Wei
    Yen, Der-Jen
    Hu, Chaur-Jong
    Lin, Cheng-Li
    Kao, Chia-Hung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 462 - 466
  • [4] Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: A nationwide study
    Shih, Chia-Jen
    Chu, Hsi
    Ou, Shuo-Ming
    Chen, Yung-Tai
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 199 : 283 - 289
  • [5] Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
    Agostini, Livia da Cunha
    Silva, Nayara Nascimento Toledo
    Belo, Vanessa de Almeida
    Luizon, Marcelo Rizzatti
    Lima, Angelica Alves
    da Silva, Glenda Nicioli
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 981
  • [6] Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis
    Shen, Jenny I.
    Saxena, Anjali B.
    Montez-Rath, Maria E.
    Leng, Lynn
    Chang, Tara I.
    Winkelmayer, Wolfgang C.
    JOURNAL OF NEPHROLOGY, 2017, 30 (02) : 281 - 288
  • [7] Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis
    Jenny I. Shen
    Anjali B. Saxena
    Maria E. Montez-Rath
    Lynn Leng
    Tara I. Chang
    Wolfgang C. Winkelmayer
    Journal of Nephrology, 2017, 30 : 281 - 288
  • [8] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Holloway-Kew, Kara L.
    Betson, Amelia G.
    Anderson, Kara B.
    Sepetavc, Filip
    Gaston, James
    Kotowicz, Mark A.
    Liao, Wan-Hui
    Henneberg, Maciej
    Pasco, Julie A.
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (04) : 396 - 408
  • [9] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Kara L. Holloway-Kew
    Amelia G. Betson
    Kara B. Anderson
    Filip Sepetavc
    James Gaston
    Mark A. Kotowicz
    Wan-Hui Liao
    Maciej Henneberg
    Julie A. Pasco
    Calcified Tissue International, 2022, 111 : 396 - 408
  • [10] Receipt of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers among Medicare beneficiaries with diabetes and hypertension
    Wang, Junling
    Surbhi, Satya
    Kuhle, Julie W.
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2014, 5 (01) : 67 - 74
12345